Claims
- 1. An oside compound selected from the group consisting of compounds that have the formula: ##STR15## wherein: X is a sulfur atom or an oxygen atom;
- Y is a hydrogen atom or a C.sub.2 -C.sub.5 aliphatic acyl group;
- R.sub.1, R.sub.2 and R.sub.3, which are identical or different, each are selected from the group consisting of a hydrogen atom, a nitro group, a cyano group, --CO--R, an amino group, an acetamido group (NHCOCH.sub.3), a C.sub.1 -C.sub.4 alkoxy group, a trifluoromethyl group and a phenyl group, which is substituted by one or more cyano, nitro or trifluoromethyl group; or
- R.sub.1 and R.sub.2, together, with the phenyl group to which they are bonded, form a .beta.-napthalenyl group, which is unsubstituted or substituted by one or more cyano, nitro or trifluoromethyl groups and R.sub.3 is selected from the group consisting of a hydrogen atom, a nitro group, a cyano group, --CO--R, an amino group, an acetamido group (NHCOCH.sub.3), a C.sub.1 -C.sub.4 alkoxy group, a trifluoromethyl group and a phenyl group, which is substituted by one or more cyano, nitro or trifluoromethyl groups; and
- R is a C.sub.1 -C.sub.4 alkyl group or a trifluoromethyl group; and wherein Y is a C.sub.2 -C.sub.5 aliphatic acyl group when R.sub.1 .dbd.R.sub.2 .dbd.R.sub.3 .dbd.H.
- 2. The oside compound of claim 1, wherein R.sub.1 is a hydrogen atom and at least one of the radicals R.sub.2 and R.sub.3 is a cyano group.
- 3. The oside compound of claim 1, wherein Y is a C.sub.2 -C.sub.5 aliphatic acyl group.
- 4. The oside compound of claim 3, wherein Y is CH.sub.3 CO.
- 5. 4-Cyanophenyl 5-thio-.beta.-D-xylopyranoside.
- 6. 3-Cyanophenyl 5-thio-.beta.-D-xylopyranoside.
- 7. 2-Nitrophenyl 5-thio-.beta.-D-xylopyranoside.
- 8. 2-Cyanophenyl 5-thio-.beta.-D-xylopyranoside.
- 9. 4-Cyanophenyl 1,5-dithio-.beta.-D-xylopyranoside.
- 10. 2,4-Dicyanophenyl 1,5-dithio-.beta.-D-xylopyranoside.
- 11. 4-Cyanophenyl 2,3,4-tri-O-acetyl-1,5-dithio-.beta.-D-xylopyranoside.
- 12. A therapeutic composition having at least one oside compound of claim 1 and a physiologically acceptable excipient.
- 13. A method of treating disorders of the venous circulation, which comprises administering to a patient in need of such a treatment an antithrombotically effective amount of a .beta.-D-phenylthioxyloside of formula I according to claim 1.
Priority Claims (2)
Number |
Date |
Country |
Kind |
88 13688 |
Oct 1988 |
FRX |
|
89 08253 |
Jun 1989 |
FRX |
|
Parent Case Info
This is a continuation of application Ser. No. 07/423,958 filed Oct. 18, 1989 now U.S. Pat. No. 5,101,048.
US Referenced Citations (3)
Foreign Referenced Citations (4)
Number |
Date |
Country |
0008881 |
Mar 1980 |
EPX |
0118676 |
Sep 1984 |
EPX |
0133103 |
Feb 1985 |
EPX |
0224849 |
Jun 1987 |
EPX |
Continuations (1)
|
Number |
Date |
Country |
Parent |
423958 |
Oct 1989 |
|